[조사자료] 글로벌 투렛 증후군 치료제 시장 2023-2027 : 항정신성 약물, 비항정신성 약물

■ 영문 제목 : Global Tourettes Syndrome Drugs Market 2023-2027
	■ 상품코드 : IRTNTR75738-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 6월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,375,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,400,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

세계의 투렛 증후군 치료제 시장 2023-2027
투렛 증후군 치료제 시장은 2022년부터 2027년까지 5억 9,885만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 6.69%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 투렛 증후군 치료제 시장에 대해 시장 규모, 예측, 동향, 성장 촉진 요인, 과제 등 전반적인 분석과 함께 약 25개 벤더를 대상으로 한 벤더 분석도 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 투렛 증후군에 대한 인식의 증가, 세계적으로 증가하는 투렛 증후군 사례, 비용 효율적인 치료법에 대한 수요 증가 등이 시장을 주도하고 있습니다.

Technavio사의 투렛 증후군 치료제 시장은 다음과 같이 분류하고 있습니다.

제품별
- 항정신성 약물
- 비항정신성 약물

유통 채널별
- 오프라인
- 온라인

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 연구는 향후 몇 년 동안 투렛 증후군 치료제 시장의 성장을 촉진하는 주요 이유 중 하나로 투렛 증후군에 대한 R&D 투자 증가를 꼽고 있습니다. 또한, 공급업체 간의 전략적 제휴 증가와 의료 인프라 지출 증가는 시장의 대규모 수요로 이어질 것으로 예상되고 있습니다.

이 보고서는 다음과 같은 분야를 다루고 있습니다.
- 투렛 증후군 치료제 시장 규모
- 투렛 증후군 치료제 시장 예측
- 투렛 증후군 치료제 시장 산업 분석

강력한 벤더 분석은 고객이 시장 지위를 향상시킬 수 있도록 설계되었으며, 이에 따라 이 보고서는 Asarina Pharma AB, AstraZeneca, Bausch Health Co. Inc., Catalyst Pharmaceuticals Inc., Eli Lilly and Co., Emalex Biosciences Inc., H Lundbeck AS, Johnson and Johnson Services Inc., Medtronic Plc, OtsUKa Holdings Co. Ltd., Paragon Biosciences LLC, Questex LLC, Reviva Pharmaceuticals Holdings Inc, Sun Pharmaceutical Industries Ltd., 및 Teva Pharmaceutical Industries Ltd. 등의 기업 정보를 포함하고 있습니다. 또한, 투렛 증후군 치료제 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것입니다.

이 조사는 업계 주요 참여자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 투렛 증후군 치료제 시장 현황
3. 세계의 투렛 증후군 치료제 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 제품별 시장 분석
7. 유통 채널별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global Tourettes syndrome drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global tourettes syndrome drugs market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Antipsychotics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Antipsychotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Antipsychotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Antipsychotics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antipsychotics – Year-over-year growth 2022-2027 (%)
o 6.4 Non-antipsychotics – Market size and forecast 2022-2027
o Exhibit 38: Chart on Non-antipsychotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Non-antipsychotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Non-antipsychotics – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Non-antipsychotics – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Asarina Pharma AB
o Exhibit 107: Asarina Pharma AB – Overview
o Exhibit 108: Asarina Pharma AB – Product / Service
o Exhibit 109: Asarina Pharma AB – Key offerings
o 12.4 AstraZeneca
o Exhibit 110: AstraZeneca – Overview
o Exhibit 111: AstraZeneca – Product / Service
o Exhibit 112: AstraZeneca – Key news
o Exhibit 113: AstraZeneca – Key offerings
o 12.5 Bausch Health Co. Inc.
o Exhibit 114: Bausch Health Co. Inc. – Overview
o Exhibit 115: Bausch Health Co. Inc. – Business segments
o Exhibit 116: Bausch Health Co. Inc. – Key news
o Exhibit 117: Bausch Health Co. Inc. – Key offerings
o Exhibit 118: Bausch Health Co. Inc. – Segment focus
o 12.6 Catalyst Pharmaceuticals Inc.
o Exhibit 119: Catalyst Pharmaceuticals Inc. – Overview
o Exhibit 120: Catalyst Pharmaceuticals Inc. – Product / Service
o Exhibit 121: Catalyst Pharmaceuticals Inc. – Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 122: Eli Lilly and Co. – Overview
o Exhibit 123: Eli Lilly and Co. – Product / Service
o Exhibit 124: Eli Lilly and Co. – Key news
o Exhibit 125: Eli Lilly and Co. – Key offerings
o 12.8 Emalex Biosciences Inc.
o Exhibit 126: Emalex Biosciences Inc. – Overview
o Exhibit 127: Emalex Biosciences Inc. – Product / Service
o Exhibit 128: Emalex Biosciences Inc. – Key offerings
o 12.9 H Lundbeck AS
o Exhibit 129: H Lundbeck AS – Overview
o Exhibit 130: H Lundbeck AS – Product / Service
o Exhibit 131: H Lundbeck AS – Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 132: Johnson and Johnson Services Inc. – Overview
o Exhibit 133: Johnson and Johnson Services Inc. – Business segments
o Exhibit 134: Johnson and Johnson Services Inc. – Key news
o Exhibit 135: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 136: Johnson and Johnson Services Inc. – Segment focus
o 12.11 Medtronic Plc
o Exhibit 137: Medtronic Plc – Overview
o Exhibit 138: Medtronic Plc – Business segments
o Exhibit 139: Medtronic Plc – Key news
o Exhibit 140: Medtronic Plc – Key offerings
o Exhibit 141: Medtronic Plc – Segment focus
o 12.12 Otsuka Holdings Co. Ltd.
o Exhibit 142: Otsuka Holdings Co. Ltd. – Overview
o Exhibit 143: Otsuka Holdings Co. Ltd. – Business segments
o Exhibit 144: Otsuka Holdings Co. Ltd. – Key offerings
o Exhibit 145: Otsuka Holdings Co. Ltd. – Segment focus
o 12.13 Paragon Biosciences LLC
o Exhibit 146: Paragon Biosciences LLC – Overview
o Exhibit 147: Paragon Biosciences LLC – Product / Service
o Exhibit 148: Paragon Biosciences LLC – Key offerings
o 12.14 Questex LLC
o Exhibit 149: Questex LLC – Overview
o Exhibit 150: Questex LLC – Product / Service
o Exhibit 151: Questex LLC – Key offerings
o 12.15 Reviva Pharmaceuticals Holdings Inc
o Exhibit 152: Reviva Pharmaceuticals Holdings Inc – Overview
o Exhibit 153: Reviva Pharmaceuticals Holdings Inc – Product / Service
o Exhibit 154: Reviva Pharmaceuticals Holdings Inc – Key offerings
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 155: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 156: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 157: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global tourettes syndrome drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antipsychotics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antipsychotics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antipsychotics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antipsychotics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-antipsychotics – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-antipsychotics – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-antipsychotics – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-antipsychotics – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Asarina Pharma AB – Overview
Exhibits108: Asarina Pharma AB – Product / Service
Exhibits109: Asarina Pharma AB – Key offerings
Exhibits110: AstraZeneca – Overview
Exhibits111: AstraZeneca – Product / Service
Exhibits112: AstraZeneca – Key news
Exhibits113: AstraZeneca – Key offerings
Exhibits114: Bausch Health Co. Inc. – Overview
Exhibits115: Bausch Health Co. Inc. – Business segments
Exhibits116: Bausch Health Co. Inc. – Key news
Exhibits117: Bausch Health Co. Inc. – Key offerings
Exhibits118: Bausch Health Co. Inc. – Segment focus
Exhibits119: Catalyst Pharmaceuticals Inc. – Overview
Exhibits120: Catalyst Pharmaceuticals Inc. – Product / Service
Exhibits121: Catalyst Pharmaceuticals Inc. – Key offerings
Exhibits122: Eli Lilly and Co. – Overview
Exhibits123: Eli Lilly and Co. – Product / Service
Exhibits124: Eli Lilly and Co. – Key news
Exhibits125: Eli Lilly and Co. – Key offerings
Exhibits126: Emalex Biosciences Inc. – Overview
Exhibits127: Emalex Biosciences Inc. – Product / Service
Exhibits128: Emalex Biosciences Inc. – Key offerings
Exhibits129: H Lundbeck AS – Overview
Exhibits130: H Lundbeck AS – Product / Service
Exhibits131: H Lundbeck AS – Key offerings
Exhibits132: Johnson and Johnson Services Inc. – Overview
Exhibits133: Johnson and Johnson Services Inc. – Business segments
Exhibits134: Johnson and Johnson Services Inc. – Key news
Exhibits135: Johnson and Johnson Services Inc. – Key offerings
Exhibits136: Johnson and Johnson Services Inc. – Segment focus
Exhibits137: Medtronic Plc – Overview
Exhibits138: Medtronic Plc – Business segments
Exhibits139: Medtronic Plc – Key news
Exhibits140: Medtronic Plc – Key offerings
Exhibits141: Medtronic Plc – Segment focus
Exhibits142: Otsuka Holdings Co. Ltd. – Overview
Exhibits143: Otsuka Holdings Co. Ltd. – Business segments
Exhibits144: Otsuka Holdings Co. Ltd. – Key offerings
Exhibits145: Otsuka Holdings Co. Ltd. – Segment focus
Exhibits146: Paragon Biosciences LLC – Overview
Exhibits147: Paragon Biosciences LLC – Product / Service
Exhibits148: Paragon Biosciences LLC – Key offerings
Exhibits149: Questex LLC – Overview
Exhibits150: Questex LLC – Product / Service
Exhibits151: Questex LLC – Key offerings
Exhibits152: Reviva Pharmaceuticals Holdings Inc – Overview
Exhibits153: Reviva Pharmaceuticals Holdings Inc – Product / Service
Exhibits154: Reviva Pharmaceuticals Holdings Inc – Key offerings
Exhibits155: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits156: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits157: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations

※본 조사보고서 [글로벌 투렛 증후군 치료제 시장 2023-2027 : 항정신성 약물, 비항정신성 약물] (코드 : IRTNTR75738-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 투렛 증후군 치료제 시장 2023-2027 : 항정신성 약물, 비항정신성 약물] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027 : 통신, 충돌 회피,내비게이션,추진,이미징
IRTNTR75836-23 / Technavio / 2023년 6월 / 글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027년 자율 무인 잠수정 (AUV) 시장은 2022년에서 2027년까지 19억 8,504만 달러 규모로 성장하여, 예측 기간 동안 16.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 자율...1. 개요 2. 세계의 자율 무인 잠수정 (AUV) 시장 현황 3. 세계의 자율 무인 잠수정 (AUV) 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 기술별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13....

글로벌 불소 시장 2023-2027 : 제약 등급, 산업용 등급
IRTNTR75995-23 / Technavio / 2023년 7월 / 글로벌 불소 시장 2023-2027 불소 시장은 2022년부터 2027년까지 1억 5,105만 달러로 성장하며, 예측 기간 동안 3.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 불소 시장에 대한 전반적인 분석, 시장 규모와 예측,...1. 개요 2. 세계의 불소 시장 현황 3. 세계의 불소 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...

글로벌 트렌볼론 에난네이트 시장 2023-2027 : 경구제, 주사제
IRTNTR75740-23 / Technavio / 2023년 6월 / 세계의 트렌볼론 에난네이트 시장 2023-2027 트렌볼론 에난네이트 시장은 2022년부터 2027년까지 1,397만 달러로 성장하며, 예측 기간 동안 3.42%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 트렌볼론 에난네이트 시장의 전반적인 분석, 시장 규모...1. 개요 2. 세계의 트렌볼론 에난네이트 시장 현황 3. 세계의 트렌볼론 에난네이트 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록...

글로벌 스타틴 시장 2023-2027 : 병원, 클리닉, 기타
IRTNTR75841-23 / Technavio / 2023년 7월 / 글로벌 스타틴 시장 2023-2027 스타틴 시장은 2022년에서 2027년까지 26억 7661만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 3.36%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 스타틴 시장에 대한 전반적인 분석,...1. 개요 2. 세계의 스타틴 시장 현황 3. 세계의 스타틴 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 최종 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...

글로벌 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 2023-2027 : 병원, 전문 클리닉, 재택 의료
IRTNTR75785-23 / Technavio / 2023년 6월 / 글로벌 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 2023-2027 시신경 척수염 스펙트럼 장애 (NMOSD) 시장은 2022년에서 2027년까지 1억 7,348만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 6.16%의 CAGR을 기록할 것으로...1. 개요 2. 세계의 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 현황 3. 세계의 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업...